{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:28:49Z","timestamp":1794716929217,"version":"4.9.1"},"publisher-location":"Cham","reference-count":134,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031118357","type":"print"},{"value":"9783031118364","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-3-031-11836-4_1","type":"book-chapter","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T06:02:54Z","timestamp":1663221774000},"page":"3-19","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nuclear Receptors in Pregnancy and Outcomes: Clinical Perspective"],"prefix":"10.1007","author":[{"given":"Luiza","family":"Borges Manna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"issue":"3","key":"1_CR1","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1478-3231.2009.02183.x","volume":"30","author":"JJ Bustamante","year":"2010","unstructured":"Bustamante JJ, Copple BL, Soares MJ, Dai G (2010) Gene profiling of maternal hepatic adaptations to pregnancy. Liver Int 30(3):406\u2013415","journal-title":"Liver Int"},{"issue":"6","key":"1_CR2","doi-asserted-by":"publisher","first-page":"615.e1","DOI":"10.1016\/j.ajog.2008.11.037","volume":"200","author":"JJ Brosens","year":"2009","unstructured":"Brosens JJ, Parker MG, McIndoe A, Pijnenborg R, Brosens IA (2009) A role for menstruation in preconditioning the uterus for successful pregnancy. Am J Obstet Gynecol 200(6):615.e1\u2013615.e6","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"1_CR3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/rmb2.12088","volume":"17","author":"H Okada","year":"2018","unstructured":"Okada H, Tsuzuki T, Murata H (2018) Decidualization of the human endometrium. Reprod Med Biol 17(3):220","journal-title":"Reprod Med Biol"},{"issue":"6","key":"1_CR4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1055\/s-2007-991042","volume":"25","author":"B Gellersen","year":"2007","unstructured":"Gellersen B, Brosens I, Brosens J (2007) Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives. Semin Reprod Med 25(6):445\u2013453","journal-title":"Semin Reprod Med"},{"key":"1_CR5","doi-asserted-by":"publisher","first-page":"1256S","DOI":"10.1093\/ajcn\/71.5.1256s","volume":"71","author":"NF Butte","year":"2000","unstructured":"Butte NF (2000) Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr 71:1256S\u20131261S. American Society for Nutrition","journal-title":"Am J Clin Nutr"},{"key":"1_CR6","first-page":"59","volume":"65","author":"E Herrera","year":"2006","unstructured":"Herrera E, Amusquivar E, L\u00f3pez-Soldado I, Ortega H (2006) Maternal lipid metabolism and placental lipid transfer. Horm Res 65:59\u201364","journal-title":"Horm Res"},{"issue":"2","key":"1_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.siny.2008.09.004","volume":"14","author":"DR Hadden","year":"2009","unstructured":"Hadden DR, McLaughlin C (2009) Normal and abnormal maternal metabolism during pregnancy. Semin Fetal Neonatal Med 14(2):66\u201371","journal-title":"Semin Fetal Neonatal Med"},{"issue":"8","key":"1_CR8","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.bbadis.2010.11.001","volume":"1812","author":"G Papacleovoulou","year":"2011","unstructured":"Papacleovoulou G, Abu-Hayyeh S, Williamson C (2011) Nuclear receptor-driven alterations in bile acid and lipid metabolic pathways during gestation. Biochim Biophys Acta Mol basis Dis 1812(8):879\u2013887","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"issue":"7","key":"1_CR9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.tem.2018.04.001","volume":"29","author":"S-P Wu","year":"2018","unstructured":"Wu S-P, Li R, Demayo FJ (2018) Progesterone receptor regulation of uterine adaptation for pregnancy. Trends Endocrinol Metab 29(7):481\u2013491","journal-title":"Trends Endocrinol Metab"},{"issue":"1\u20135","key":"1_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jsbmb.2006.09.006","volume":"102","author":"K Lee","year":"2006","unstructured":"Lee K, Jeong J, Tsai M-J, Tsai S, Lydon JP, Demayo FJ (2006) Molecular mechanisms involved in progesterone receptor regulation of uterine function. J Steroid Biochem Mol Biol 102(1\u20135):41\u201350","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5485","key":"1_CR11","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1126\/science.289.5485.1751","volume":"289","author":"B Mullac-Jericevic","year":"2000","unstructured":"Mullac-Jericevic B, Mullinax RA, DeMayo FJ, Lydon JP, Conneely OM (2000) Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science 289(5485):1751\u20131754","journal-title":"Science"},{"issue":"17","key":"1_CR12","doi-asserted-by":"publisher","first-page":"9744","DOI":"10.1073\/pnas.1732707100","volume":"100","author":"B Mulac-Jericevic","year":"2003","unstructured":"Mulac-Jericevic B, Lydon JP, DeMayo FJ, Conneely OM (2003) Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc Natl Acad Sci U S A 100(17):9744","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/molehr\/gap013","volume":"15","author":"MC Fleisch","year":"2009","unstructured":"Fleisch MC, Chou YC, Cardiff RD, Asaithambi A, Shyamala G (2009) Overexpression of progesterone receptor a isoform in mice leads to endometrial hyperproliferation, hyperplasia and atypia. Mol Hum Reprod 15(4):241\u2013249","journal-title":"Mol Hum Reprod"},{"issue":"4","key":"1_CR14","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1242\/jcs.99.4.681","volume":"99","author":"J Aplin","year":"1991","unstructured":"Aplin J (1991) Implantation, trophoblast differentiation and haemochorial placentation: mechanistic evidence in vivo and in vitro. J Cell Sci 99(4):681\u2013692","journal-title":"J Cell Sci"},{"issue":"5","key":"1_CR15","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.mam.2012.12.008","volume":"34","author":"L Ji","year":"2013","unstructured":"Ji L, Brki\u0107 J, Liu M, Fu G, Peng C, Wang YL (2013) Placental trophoblast cell differentiation: physiological regulation and pathological relevance to preeclampsia. Mol Asp Med 34(5):981\u20131023","journal-title":"Mol Asp Med"},{"issue":"2","key":"1_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3109\/19396368.2014.991881","volume":"61","author":"L Kadam","year":"2015","unstructured":"Kadam L, Kohan-Ghadr HR, Drewlo S (2015) The balancing act \u2013 PPAR-\u03b3\u2019s roles at the maternal-fetal interface. Syst Biol Reprod Med 61(2):65\u201371","journal-title":"Syst Biol Reprod Med"},{"issue":"2","key":"1_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jri.2007.05.004","volume":"77","author":"T Fournier","year":"2008","unstructured":"Fournier T, Handschuh K, Tsatsaris V, Guibourdenche J, Evain-Brion D (2008) Role of nuclear receptors and their ligands in human trophoblast invasion. J Reprod Immunol 77(2):161\u2013170","journal-title":"J Reprod Immunol"},{"issue":"4","key":"1_CR18","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S1097-2765(00)80209-9","volume":"4","author":"Y Barak","year":"1999","unstructured":"Barak Y, Nelson MC, Ong ES et al (1999) PPAR\u03b3 is required for placental, cardiac, and adipose tissue development. Mol Cell 4(4):585\u2013595","journal-title":"Mol Cell"},{"issue":"10","key":"1_CR19","first-page":"5017","volume":"86","author":"A Tarrade","year":"2001","unstructured":"Tarrade A, Schoonjans K, Pavan L et al (2001) PPAR\u03b3\/RXR\u03b1 heterodimers control human trophoblast invasion. J Clin Endocrinol Metab 86(10):5017\u20135024","journal-title":"J Clin Endocrinol Metab"},{"issue":"8\u20139","key":"1_CR20","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.placenta.2007.06.007","volume":"28","author":"T Fournier","year":"2007","unstructured":"Fournier T, Handschuh K, Tsatsaris V, Evain-Brion D (2007) Involvement of PPARgamma in human trophoblast invasion. Placenta 28(8\u20139):974\u2013976","journal-title":"Placenta"},{"issue":"28","key":"1_CR21","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.2174\/092986708786848677","volume":"15","author":"T Fournier","year":"2008","unstructured":"Fournier T, Th\u00e9rond P, Handschuh K, Tsatsaris V (2008) Evain-Brion. PPARgamma and early human placental development. Curr Med Chem 15(28):3011\u20133024","journal-title":"Curr Med Chem"},{"key":"1_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1749-6632.2002.tb04601.x","volume":"973","author":"T Fournier","year":"2002","unstructured":"Fournier T, Pavan L, Tarrade A et al (2002) The role of PPAR-\u03b3\/RXR-\u03b1 heterodimers in the regulation of human trophoblast invasion. Ann N Y Acad Sci 973:26\u201330","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"1_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008055","volume":"4","author":"MM Parast","year":"2009","unstructured":"Parast MM, Yu H, Ciric A, Salata MW, Davis V, Milstone DS (2009) PPAR\u03b3 regulates trophoblast proliferation and promotes labyrinthine Trilineage differentiation. PLoS One 4(11):e8055","journal-title":"PLoS One"},{"issue":"10","key":"1_CR24","first-page":"3874","volume":"85","author":"WT Schaiff","year":"2000","unstructured":"Schaiff WT, Carlson MG, Smith SD, Levy R, Nelson DM, Sadovsky Y (2000) Peroxisome proliferator-activated receptor-gamma modulates differentiation of human trophoblast in a ligand-specific manner. J Clin Endocrinol Metab 85(10):3874\u20133881","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm3312","volume":"13","author":"AC Calkin","year":"2012","unstructured":"Calkin AC, Tontonoz P (2012) Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nat Rev Mol Cell Biol 13(4):213\u2013224","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5548","key":"1_CR26","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1126\/science.294.5548.1866","volume":"294","author":"A Chawta","year":"2001","unstructured":"Chawta A, Repa JJ, Evans RM, Mangelsdorf DJ (2001) Nuclear receptors and lipid physiology: Opening the x-files. Science (80-) 294(5548):1866\u20131870","journal-title":"Science (80-)"},{"issue":"10","key":"1_CR27","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.placenta.2004.10.005","volume":"26","author":"MS Weedon-Fekjaer","year":"2005","unstructured":"Weedon-Fekjaer MS, Duttaroy AK, Nebb HI (2005) Liver X receptors mediate inhibition of hCG secretion in a human placental trophoblast cell line. Placenta 26(10):721\u2013728","journal-title":"Placenta"},{"issue":"6602","key":"1_CR28","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/383728a0","volume":"383","author":"BA Janowski","year":"1996","unstructured":"Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ (1996) An oxysterol signalling pathway mediated by the nuclear receptor LXR\u03b1. Nature 383(6602):728\u2013731","journal-title":"Nature"},{"issue":"10","key":"1_CR29","doi-asserted-by":"publisher","first-page":"4583","DOI":"10.1210\/en.2003-1747","volume":"145","author":"L Pavan","year":"2004","unstructured":"Pavan L, Hermouet A, Tsatsaris V et al (2004) Lipids from oxidized low-density lipoprotein modulate human trophoblast invasion: involvement of nuclear liver X receptors. Endocrinology 145(10):4583\u20134591","journal-title":"Endocrinology"},{"issue":"2","key":"1_CR30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.placenta.2010.12.007","volume":"32","author":"IL Aye","year":"2011","unstructured":"Aye IL, Waddell BJ, Mark PJ, Keelan JA (2011) Oxysterols inhibit differentiation and fusion of term primary trophoblasts by activating liver X receptors. Placenta 32(2):183\u2013191","journal-title":"Placenta"},{"issue":"11","key":"1_CR31","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.placenta.2014.09.002","volume":"35","author":"JC Larkin","year":"2014","unstructured":"Larkin JC, Sears SB, Sadovsky Y (2014) The influence of ligand-activated LXR on primary human trophoblasts. Placenta 35(11):919","journal-title":"Placenta"},{"issue":"10","key":"1_CR32","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1194\/jlr.M500080-JLR200","volume":"46","author":"SL Sabol","year":"2005","unstructured":"Sabol SL, Brewer HB, Santamarina-Fojo S (2005) The human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver. J Lipid Res 46(10):2151\u20132167","journal-title":"J Lipid Res"},{"issue":"22","key":"1_CR33","doi-asserted-by":"publisher","first-page":"12097","DOI":"10.1073\/pnas.200367697","volume":"97","author":"A Venkateswaran","year":"2000","unstructured":"Venkateswaran A, Laffitte BA, Joseph SB et al (2000) Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR\u03b1. Proc Natl Acad Sci U S A 97(22):12097\u201312102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1_CR34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1146\/annurev.physiol.68.033104.152158","volume":"68","author":"NY Kalaany","year":"2006","unstructured":"Kalaany NY, Mangelsdorf DJ (2006) LXRS AND FXR: The Yin and Yang of cholesterol and fat metabolism. Annu Rev Physiol 68(1):159\u2013191","journal-title":"Annu Rev Physiol"},{"issue":"4","key":"1_CR35","doi-asserted-by":"publisher","first-page":"E463","DOI":"10.1152\/ajpendo.00449.2016","volume":"313","author":"V Nikolova","year":"2017","unstructured":"Nikolova V, Papacleovoulou G, Bellafante E et al (2017) Changes in LXR signaling influence early-pregnancy lipogenesis and protect against dysregulated fetoplacental lipid homeostasis. Am J Physiol Endocrinol Metab 313(4):E463\u2013E472","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"1_CR36","first-page":"E1313","volume":"290","author":"TR Sweeney","year":"2006","unstructured":"Sweeney TR, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR (2006) Decreased nuclear hormone receptor expression in the livers of mice in late pregnancy. Am J Physiol Metab 290(6):E1313\u2013E1320","journal-title":"Am J Physiol Metab"},{"issue":"6009","key":"1_CR37","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1126\/science.1195027","volume":"330","author":"J Bass","year":"2010","unstructured":"Bass J, Takahashi JS (2010) Circadian integration of metabolism and energetics. Science (80-) 330(6009):1349\u20131354","journal-title":"Science (80-)"},{"issue":"7396","key":"1_CR38","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature11048","volume":"485","author":"H Cho","year":"2012","unstructured":"Cho H, Zhao X, Hatori M et al (2012) Regulation of circadian behaviour and metabolism by REV-ERB-\u03b1 and REV-ERB-\u03b2. Nature 485(7396):123\u2013127","journal-title":"Nature"},{"issue":"7","key":"1_CR39","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1101\/gad.186858.112","volume":"26","author":"A Bugge","year":"2012","unstructured":"Bugge A, Feng D, Everett LJ et al (2012) Rev-erba and Rev-erbb coordinately protect the circadian clock and normal metabolic function. Genes Dev 26(7):657\u2013667","journal-title":"Genes Dev"},{"issue":"4","key":"1_CR40","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1096\/fj.201601032R","volume":"31","author":"G Papacleovoulou","year":"2017","unstructured":"Papacleovoulou G, Nikolova V, Oduwole O et al (2017) Gestational disruptions in metabolic rhythmicity of the liver, muscle, and placenta affect fetal size. FASEB J 31(4):1698\u20131708","journal-title":"FASEB J"},{"key":"1_CR41","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.placenta.2020.02.005","volume":"92","author":"O Shynlova","year":"2020","unstructured":"Shynlova O, Nadeem L, Zhang J, Dunk C, Lye S (2020) Myometrial activation: novel concepts underlying labor. Placenta 92:28\u201336","journal-title":"Placenta"},{"issue":"11","key":"1_CR42","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1210\/me.2006-0112","volume":"20","author":"DB Hardy","year":"2006","unstructured":"Hardy DB, Janowski BA, Corey DR, Mendelson CR (2006) Progesterone receptor plays a major Antiinflammatory role in human myometrial cells by antagonism of nuclear factor-\u03baB activation of cyclooxygenase 2 expression. Mol Endocrinol 20(11):2724\u20132733","journal-title":"Mol Endocrinol"},{"issue":"11","key":"1_CR43","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.1074\/jbc.271.11.6217","volume":"271","author":"E Kalkhoven","year":"1996","unstructured":"Kalkhoven E, Wissink S, van der Saag PT, van der Burg B (1996) Negative interaction between the RelA(p65) subunit of NF-kappaB and the progesterone receptor. J Biol Chem 271(11):6217\u20136224","journal-title":"J Biol Chem"},{"key":"1_CR44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jsbmb.2016.09.006","volume":"170","author":"CR Mendelson","year":"2017","unstructured":"Mendelson CR, Montalbano AP, Gao L, Steroid J, Mol B, Author B (2017) Fetal-to-maternal signaling in the timing of birth HHS public access Author manuscript. J Steroid Biochem Mol Biol 170:19\u201327","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"1_CR45","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1095\/biolreprod52.3.547","volume":"52","author":"EM Hendrix","year":"1995","unstructured":"Hendrix EM, Myatt L, Sellers S, Russell PT, Larsen WJ (1995) Steroid hormone regulation of rat myometrial gap junction formation: effects on cx43 levels and trafficking. Biol Reprod 52(3):547\u2013560","journal-title":"Biol Reprod"},{"issue":"48","key":"1_CR46","doi-asserted-by":"publisher","first-page":"20828","DOI":"10.1073\/pnas.1008301107","volume":"107","author":"NE Renthal","year":"2010","unstructured":"Renthal NE, Chen C-C, Williams KC, Gerard RD, Prange-Kiel J, Mendelson CR (2010) miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor. Proc Natl Acad Sci 107(48):20828\u201320833","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"1_CR47","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/molehr\/gas012","volume":"18","author":"SY Chai","year":"2012","unstructured":"Chai SY, Smith R, Zakar T, Mitchell C, Madsen G (2012) Term myometrium is characterized by increased activating epigenetic modifications at the progesterone receptor-a promoter. Mol Hum Reprod 18(8):401\u2013409","journal-title":"Mol Hum Reprod"},{"key":"1_CR48","doi-asserted-by":"publisher","first-page":"11565","DOI":"10.1038\/ncomms11565","volume":"7","author":"L Nadeem","year":"2016","unstructured":"Nadeem L, Shynlova O, Matysiak-Zablocki E, Mesiano S, Dong X, Lye S (2016) Molecular evidence of functional progesterone withdrawal in human myometrium. Nat Commun 7:11565","journal-title":"Nat Commun"},{"issue":"11","key":"1_CR49","doi-asserted-by":"publisher","first-page":"e2011643118","DOI":"10.1073\/pnas.2011643118","volume":"118","author":"MC Peavey","year":"2021","unstructured":"Peavey MC, Wu SP, Li R et al (2021) Progesterone receptor isoform B regulates the Oxtr- Plcl2- Trpc3 pathway to suppress uterine contractility. Proc Natl Acad Sci U S A 118(11):e2011643118","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1_CR50","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1210\/jc.2007-0077","volume":"92","author":"AA Merlino","year":"2007","unstructured":"Merlino AA, Welsh TN, Tan H et al (2007) Nuclear progesterone receptors in the human pregnancy myometrium: evidence that parturition involves functional progesterone withdrawal mediated by increased expression of progesterone receptor-a. J Clin Endocrinol Metab 92(5):1927\u20131933","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1_CR51","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/molehr\/7.9.875","volume":"7","author":"D Pieber","year":"2001","unstructured":"Pieber D, Allport VC, Hills F, Johnson M, Bennett PR (2001) Interactions between progesterone receptor isoforms in myometrial cells in human labour. Mol Hum Reprod 7(9):875\u2013879","journal-title":"Mol Hum Reprod"},{"issue":"19","key":"1_CR52","doi-asserted-by":"publisher","first-page":"7529","DOI":"10.1073\/pnas.1200650109","volume":"109","author":"KC Williams","year":"2012","unstructured":"Williams KC, Renthal NE, Condon JC, Gerard RD, Mendelson CR (2012) MicroRNA-200a serves a key role in the decline of progesterone receptor function leading to term and preterm labor. Proc Natl Acad Sci U S A 109(19):7529","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"1_CR53","doi-asserted-by":"publisher","first-page":"6773","DOI":"10.1111\/jcmm.16681","volume":"25","author":"L Nadeem","year":"2021","unstructured":"Nadeem L, Balendran R, Dorogin A, Mesiano S, Shynlova O, Lye SJ (2021) Pro-inflammatory signals induce 20\u03b1-HSD expression in myometrial cells: a key mechanism for local progesterone withdrawal. J Cell Mol Med 25(14):6773","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1_CR54","doi-asserted-by":"publisher","first-page":"13357","DOI":"10.1038\/s41598-017-13488-9","volume":"7","author":"L Nadeem","year":"2017","unstructured":"Nadeem L, Shynlova O, Mesiano S, Lye S (2017) Progesterone via its type-a receptor promotes myometrial gap junction coupling. Sci Rep 7(1):13357","journal-title":"Sci Rep"},{"issue":"10","key":"1_CR55","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1111\/j.1582-4934.2012.01567.x","volume":"16","author":"Y Lee","year":"2012","unstructured":"Lee Y, Sooranna SR, Terzidou V et al (2012) Interactions between inflammatory signals and the progesterone receptor in regulating gene expression in pregnant human uterine myocytes. J Cell Mol Med 16(10):2487","journal-title":"J Cell Mol Med"},{"issue":"6","key":"1_CR56","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/molehr\/7.6.581","volume":"7","author":"VC Allport","year":"2001","unstructured":"Allport VC, Pieber D, Slater DM, Newton R, White JO, Bennett PR (2001) Human labour is associated with nuclear factor-kappaB activity which mediates cyclo-oxygenase-2 expression and is involved with the \u201cfunctional progesterone withdrawal\u201d. Mol Hum Reprod 7(6):581\u2013586","journal-title":"Mol Hum Reprod"},{"issue":"2","key":"1_CR57","doi-asserted-by":"publisher","first-page":"284","DOI":"10.4239\/wjd.v6.i2.284","volume":"6","author":"GK Poomalar","year":"2015","unstructured":"Poomalar GK (2015) Changing trends in management of gestational diabetes mellitus. World J Diabetes 6(2):284","journal-title":"World J Diabetes"},{"key":"1_CR58","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","volume":"138","author":"NH Cho","year":"2018","unstructured":"Cho NH, Shaw JE, Karuranga S et al (2018) IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 138:271\u2013281","journal-title":"Diabetes Res Clin Pract"},{"key":"1_CR59","first-page":"6145333","volume":"11","author":"H David Mcintyre","year":"2020","unstructured":"David Mcintyre H, Kapur A, Divakar H, Hod M (2020) Gestational diabetes mellitus \u2013 innovative approach to prediction, diagnosis, management, and prevention of future NCD \u2013 mother and offspring. Front Endocrinol (Lausanne) 11:6145333","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"19","key":"1_CR60","first-page":"1991","volume":"358","author":"BE Metzger","year":"2009","unstructured":"HAPO Study Cooperative Research Group, Metzger BE, Lowe LP et al (2009) Hyperglycemia and Adverse Pregnancy Outcomes. MCN 358(19):1991\u20132002","journal-title":"MCN"},{"issue":"4","key":"1_CR61","doi-asserted-by":"publisher","first-page":"878","DOI":"10.2337\/dc06-1816","volume":"30","author":"AJ Lee","year":"2007","unstructured":"Lee AJ, Hiscock RJ, Wein P, Walker SP, Permezel M (2007) Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes: a retrospective cohort study using survival analysis. Diabetes Care 30(4):878\u2013883","journal-title":"Diabetes Care"},{"issue":"6\u20137","key":"1_CR62","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1503\/cmaj.090569","volume":"181","author":"R Retnakaran","year":"2009","unstructured":"Retnakaran R, Shah BR (2009) Mild glucose intolerance in pregnancy and risk of cardiovascular disease: a population-based cohort study. CMAJ 181(6\u20137):371\u2013376","journal-title":"CMAJ"},{"issue":"6","key":"1_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22062965","volume":"22","author":"A Ornoy","year":"2021","unstructured":"Ornoy A, Becker M, Weinstein-Fudim L, Ergaz Z (2021) Diabetes during pregnancy: a maternal disease complicating the course of pregnancy with long-term deleterious effects on the offspring. A clinical review. Int J Mol Sci 22(6):1\u201338","journal-title":"Int J Mol Sci"},{"issue":"Suppl 3","key":"1_CR64","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000509902","volume":"76","author":"AH Chu","year":"2020","unstructured":"Chu AH, Godfrey KM (2020) Gestational diabetes mellitus and developmental programming. Ann Nutr Metab 76(Suppl 3):4","journal-title":"Ann Nutr Metab"},{"issue":"1","key":"1_CR65","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/cells10010099","volume":"10","author":"KCR Gregorio","year":"2021","unstructured":"Gregorio KCR, Laurindo CP, Machado UF (2021) Estrogen and glycemic homeostasis: the fundamental role of nuclear estrogen receptors ESR1\/ESR2 in glucose transporter GLUT4 regulation. Cells 10(1):90","journal-title":"Cells"},{"issue":"5","key":"1_CR66","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.dsx.2018.04.018","volume":"12","author":"EE Herrera-Lopez","year":"2018","unstructured":"Herrera-Lopez EE, Castelan-Martinez OD, Suarez Sanchez F et al (2018) The rs1256031 of estrogen receptor \u03b2 gene is associated with type 2 diabetes. Diabetes Metab Syndr 12(5):631\u2013633","journal-title":"Diabetes Metab Syndr"},{"issue":"4","key":"1_CR67","first-page":"703","volume":"82","author":"X Li","year":"2020","unstructured":"Li X, Su J, Zheng K et al (2020) Assessment of the association between the polymorphism rs1256031 of the estrogen receptor \u03b2 gene and GDM susceptibility. Nagoya J Med Sci 82(4):703","journal-title":"Nagoya J Med Sci"},{"issue":"1","key":"1_CR68","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000502378","volume":"85","author":"C Li","year":"2020","unstructured":"Li C, Qiao B, Zhou Y, Qi W, Ma C, Zheng L (2020) Asociation of estrogen receptor \u03b1 gene polymorphism and its expression with gestational diabetes mellitus. Gynecol Obstet Investig 85(1):26\u201333","journal-title":"Gynecol Obstet Investig"},{"issue":"4","key":"1_CR69","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1210\/er.2012-1041","volume":"34","author":"S Hocking","year":"2013","unstructured":"Hocking S, Samocha-Bonet D, Milner KL, Greenfield JR, Chisholm DJ (2013) Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots. Endocr Rev 34(4):463\u2013500","journal-title":"Endocr Rev"},{"issue":"8","key":"1_CR70","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3390\/nu8080466","volume":"8","author":"SM Kitessa","year":"2016","unstructured":"Kitessa SM, Abeywardena MY (2016) Lipid-induced insulin resistance in skeletal muscle: the chase for the culprit Goes from total intramuscular fat to lipid intermediates, and finally to species of lipid intermediates. Nutrients 8(8):466","journal-title":"Nutrients"},{"issue":"9","key":"1_CR71","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/j.1464-5491.2007.02186.x","volume":"24","author":"JP Wilding","year":"2007","unstructured":"Wilding JP (2007) The importance of free fatty acids in the development of Type 2 diabetes. Diabet Med 24(9):934\u2013945","journal-title":"Diabet Med"},{"issue":"4","key":"1_CR72","doi-asserted-by":"publisher","first-page":"e0124778","DOI":"10.1371\/journal.pone.0124778","volume":"10","author":"Y Dong","year":"2015","unstructured":"Dong Y, Gao G, Fan H, Li S, Li X, Liu W (2015) Activation of the liver X receptor by Agonist TO901317 improves hepatic insulin resistance via suppressing reactive oxygen species and JNK pathway. PLoS ONE 10(4):e0124778","journal-title":"PLoS ONE"},{"issue":"7","key":"1_CR73","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1210\/en.2016-1941","volume":"158","author":"J Maczewsky","year":"2017","unstructured":"Maczewsky J, Sikimic J, Bauer C et al (2017) The LXR ligand T0901317 acutely inhibits insulin secretion by affecting mitochondrial metabolism. Endocrinology 158(7):2145\u20132154","journal-title":"Endocrinology"},{"key":"1_CR74","first-page":"7518599","volume":"2014","author":"L Ding","year":"2014","unstructured":"Ding L, Pang S, Sun Y, Tian Y, Yu L, Dang N (2014) Coordinated actions of FXR and LXR in metabolism: from pathogenesis to pharmacological targets for type 2 diabetes. Int J Endocrinol 2014:7518599","journal-title":"Int J Endocrinol"},{"issue":"2","key":"1_CR75","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.metabol.2013.10.001","volume":"63","author":"M Lappas","year":"2014","unstructured":"Lappas M (2014) Effect of pre-existing maternal obesity, gestational diabetes and adipokines on the expression of genes involved in lipid metabolism in adipose tissue. Metabolism 63(2):250\u2013262","journal-title":"Metabolism"},{"issue":"4","key":"1_CR76","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1172\/JCI25604","volume":"116","author":"K Ma","year":"2006","unstructured":"Ma K, Saha PK, Chan L, Moore DD (2006) Farnesoid X receptor is essential for normal glucose homeostasis. J Clin Invest 116(4):1102\u20131109","journal-title":"J Clin Invest"},{"issue":"1","key":"1_CR77","doi-asserted-by":"publisher","first-page":"11523","DOI":"10.1038\/s41598-020-67968-6","volume":"10","author":"E Bellafante","year":"2020","unstructured":"Bellafante E, McIlvride S, Nikolova V et al (2020) Maternal glucose homeostasis is impaired in mouse models of gestational cholestasis. Sci Rep 10(1):11523","journal-title":"Sci Rep"},{"issue":"3","key":"1_CR78","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1053\/j.gastro.2013.05.042","volume":"145","author":"S Mudaliar","year":"2013","unstructured":"Mudaliar S, Henry RR, Sanyal AJ et al (2013) Efficacy and safety of the farnesoid x receptor agonist Obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease. Gastroenterology 145(3):574","journal-title":"Gastroenterology"},{"issue":"2","key":"1_CR79","doi-asserted-by":"publisher","first-page":"E399","DOI":"10.1152\/ajpendo.00407.2018","volume":"317","author":"S McIlvride","year":"2019","unstructured":"McIlvride S, Nikolova V, Fan HM et al (2019) Obeticholic acid ameliorates dyslipidemia but not glucose tolerance in mouse model of gestational diabetes. Am J Physiol Endocrinol Metab 317(2):E399\u2013E410","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"9","key":"1_CR80","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/sj.jp.7211545","volume":"26","author":"RH Lee","year":"2006","unstructured":"Lee RH, Goodwin TM, Greenspoon J, Incerpi M (2006) The prevalence of intrahepatic cholestasis of pregnancy in a primarily Latina Los Angeles population. J Perinatol 26(9):527\u2013532","journal-title":"J Perinatol"},{"issue":"2","key":"1_CR81","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/OGX.0000000000000524","volume":"73","author":"AM Wood","year":"2018","unstructured":"Wood AM, Livingston EG, Hughes BL, Kuller JA (2018) Intrahepatic cholestasis of pregnancy: a review of diagnosis and management. Obstet Gynecol Surv 73(2):103\u2013109","journal-title":"Obstet Gynecol Surv"},{"issue":"4","key":"1_CR82","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1002\/hep.26617","volume":"59","author":"V Geenes","year":"2014","unstructured":"Geenes V, Chappell LC, Seed PT, Steer PJ, Knight M, Williamson C (2014) Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study. Hepatology 59(4):1482\u20131491","journal-title":"Hepatology"},{"issue":"10174","key":"1_CR83","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0140-6736(18)31877-4","volume":"393","author":"C Ovadia","year":"2019","unstructured":"Ovadia C, Seed PT, Sklavounos A et al (2019) Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet 393(10174):899\u2013909","journal-title":"Lancet"},{"issue":"7814","key":"1_CR84","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41586-020-2434-2","volume":"583","author":"E Turro","year":"2020","unstructured":"Turro E, Astle WJ, Megy K et al (2020) Whole-genome sequencing of patients with rare diseases in a national health system. Nature 583(7814):96\u2013102","journal-title":"Nature"},{"issue":"1","key":"1_CR85","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ajg.2013.406","volume":"109","author":"PH Dixon","year":"2014","unstructured":"Dixon PH, Wadsworth CA, Chambers J et al (2014) A comprehensive analysis of common genetic variation around six candidate loci for intrahepatic cholestasis of pregnancy. Am J Gastroenterol 109(1):76\u201384","journal-title":"Am J Gastroenterol"},{"issue":"22","key":"1_CR86","doi-asserted-by":"publisher","first-page":"16504","DOI":"10.1074\/jbc.M109.072140","volume":"285","author":"S Abu-Hayyeh","year":"2010","unstructured":"Abu-Hayyeh S, Martinez-Becerra P, Abdul Kadir SHS et al (2010) Inhibition of Na+\u2212taurocholate co-transporting polypeptide-mediated bile acid transport by cholestatic sulfated progesterone metabolites. J Biol Chem 285(22):16504\u201316512","journal-title":"J Biol Chem"},{"issue":"1","key":"1_CR87","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jhep.2007.08.015","volume":"48","author":"S Sookoian","year":"2008","unstructured":"Sookoian S, Casta\u00f1o G, Burgue\u00f1o A, Gianotti TF, Pirola CJ (2008) Association of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancy. J Hepatol 48(1):125\u2013132","journal-title":"J Hepatol"},{"issue":"7","key":"1_CR88","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1080\/07853890410018790","volume":"36","author":"SM Houten","year":"2004","unstructured":"Houten SM, Auwerx J (2004) The enterohepatic nuclear receptors are major regulators of the enterohepatic circulation of bile salts. Ann Med 36(7):482\u2013491","journal-title":"Ann Med"},{"issue":"5418","key":"1_CR89","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","volume":"284","author":"M Makishima","year":"1999","unstructured":"Makishima M, Okamoto AY, Repa JJ et al (1999) Identification of a nuclear receptor for bite acids. Science (80-) 284(5418):1362\u20131365","journal-title":"Science (80-)"},{"issue":"5418","key":"1_CR90","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","volume":"284","author":"DJ Parks","year":"1999","unstructured":"Parks DJ, Blanchard SG, Bledsoe RK et al (1999) Bile acids: Natural ligands for an orphan nuclear receptor. Science (80-) 284(5418):1365\u20131368","journal-title":"Science (80-)"},{"issue":"10","key":"1_CR91","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","volume":"50","author":"JYL Chiang","year":"2009","unstructured":"Chiang JYL (2009) Bile acids: regulation of synthesis. J Lipid Res 50(10):1955\u20131966","journal-title":"J Lipid Res"},{"issue":"3","key":"1_CR92","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","volume":"6","author":"B Goodwin","year":"2000","unstructured":"Goodwin B, Jones SA, Price RR et al (2000) A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6(3):517\u2013526","journal-title":"Mol Cell"},{"issue":"1","key":"1_CR93","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1053\/gast.2001.25503","volume":"121","author":"LA Denson","year":"2001","unstructured":"Denson LA, Sturm E, Echevarria W et al (2001) The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology 121(1):140\u2013147","journal-title":"Gastroenterology"},{"issue":"3","key":"1_CR94","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1053\/jhep.2002.31724","volume":"35","author":"M M\u00fcller","year":"2002","unstructured":"M\u00fcller M, Jansen PLM, Faber KN et al (2002) Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump. Hepatology 35(3):589\u2013596","journal-title":"Hepatology"},{"issue":"4","key":"1_CR95","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1002\/hep.23849","volume":"52","author":"A Milona","year":"2010","unstructured":"Milona A, Owen BM, Cobbold JFL et al (2010) Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function. Hepatology 52(4):1341\u20131349","journal-title":"Hepatology"},{"issue":"4","key":"1_CR96","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1210\/me.2015-1014","volume":"29","author":"Y Chen","year":"2015","unstructured":"Chen Y, Vasilenko A, Song X et al (2015) Estrogen and estrogen receptor-\u03b1-mediated Transrepression of bile salt export pump. Mol Endocrinol 29(4):613\u2013626","journal-title":"Mol Endocrinol"},{"issue":"6","key":"1_CR97","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1002\/hep.27171","volume":"60","author":"X Song","year":"2014","unstructured":"Song X, Vasilenko A, Chen Y et al (2014) Transcriptional dynamics of bile salt export pump during pregnancy: mechanisms and implications in intrahepatic cholestasis of pregnancy. Hepatology 60(6):1993\u20132007","journal-title":"Hepatology"},{"issue":"2","key":"1_CR98","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/hep.26055","volume":"57","author":"S Abu-Hayyeh","year":"2013","unstructured":"Abu-Hayyeh S, Papacleovoulou G, L\u00f6vgren-Sandblom A et al (2013) Intrahepatic cholestasis of pregnancy levels of sulfated progesterone metabolites inhibit farnesoid X receptor resulting in a cholestatic phenotype. Hepatology 57(2):716\u2013726","journal-title":"Hepatology"},{"issue":"1","key":"1_CR99","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/01.AOG.0000189096.94874.9c","volume":"107","author":"AT Dann","year":"2006","unstructured":"Dann AT, Kenyon AP, Wierzbicki AS, Seed PT, Shennan AH, Tribe RM (2006) Plasma lipid profiles of women with intrahepatic cholestasis of pregnancy. Obstet Gynecol 107(1):106\u2013114","journal-title":"Obstet Gynecol"},{"issue":"1","key":"1_CR100","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ejogrb.2013.12.037","volume":"176","author":"M Martineau","year":"2014","unstructured":"Martineau M, Raker C, Powrie R, Williamson C (2014) Intrahepatic cholestasis of pregnancy is associated with an increased risk of gestational diabetes. Eur J Obstet Gynecol Reprod Biol 176(1):80\u201385","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"1_CR101","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2337\/dc14-2143","volume":"38","author":"MG Martineau","year":"2015","unstructured":"Martineau MG, Raker C, Dixon PH et al (2015) The metabolic profile of intrahepatic cholestasis of pregnancy is associated with impaired glucose tolerance, dyslipidemia, and increased fetal growth. Diabetes Care 38(2):243\u2013248","journal-title":"Diabetes Care"},{"issue":"17","key":"1_CR102","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.3748\/wjg.15.2049","volume":"15","author":"V Geenes","year":"2009","unstructured":"Geenes V, Williamson C (2009) Intrahepatic cholestasis of pregnancy. World J Gastroenterol 15(17):2049","journal-title":"World J Gastroenterol"},{"issue":"4 Suppl 2","key":"1_CR103","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1097\/01.mcg.0000155551.37266.26","volume":"39","author":"M Trauner","year":"2005","unstructured":"Trauner M, Wagner M, Fickert P, Zollner G (2005) Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis. J Clin Gastroenterol 39(4 Suppl 2):S111\u2013S124","journal-title":"J Clin Gastroenterol"},{"issue":"10201","key":"1_CR104","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(19)31270-X","volume":"394","author":"LC Chappell","year":"2019","unstructured":"Chappell LC, Bell JL, Smith A et al (2019) Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. Lancet 394(10201):849\u2013860","journal-title":"Lancet"},{"issue":"7","key":"1_CR105","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S2468-1253(21)00074-1","volume":"6","author":"C Ovadia","year":"2021","unstructured":"Ovadia C, Sajous J, Seed PT et al (2021) Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis. Lancet Gastroenterol Hepatol 6(7):547\u2013558","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"1_CR106","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1172\/JCI68927","volume":"123","author":"G Papacleovoulou","year":"2013","unstructured":"Papacleovoulou G, Abu-Hayyeh S, Nikolopoulou E et al (2013) Maternal cholestasis during pregnancy programs metabolic disease in offspring. J Clin Invest 123(7):3172\u20133181","journal-title":"J Clin Invest"},{"issue":"1","key":"1_CR107","doi-asserted-by":"publisher","first-page":"10361","DOI":"10.1038\/s41598-020-67301-1","volume":"10","author":"L Borges Manna","year":"2020","unstructured":"Borges Manna L, Papacleovoulou G, Flaviani F et al (2020) Ursodeoxycholic acid improves feto-placental and offspring metabolic outcomes in hypercholanemic pregnancy. Sci Rep 10(1):10361","journal-title":"Sci Rep"},{"key":"1_CR108","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0140-6736(20)32335-7","volume":"3","author":"LC Chappell","year":"2021","unstructured":"Chappell LC, Cluver CA, Kingdom J, Tong S (2021) Pre-eclampsia. Lancet 3:341\u2013354","journal-title":"Lancet"},{"issue":"12","key":"1_CR109","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1111\/1471-0528.16319","volume":"127","author":"J Duffy","year":"2020","unstructured":"Duffy J, Cairns AE, Richards-Doran D et al (2020) A core outcome set for pre-eclampsia research: an international consensus development study. BJOG 127(12):1516\u20131526","journal-title":"BJOG"},{"key":"1_CR110","unstructured":"WHO recommendations: Policy of interventionist versus expectant management of severe pre-eclampsia before term. WHO Recomm Policy Interv versus Expect Manag Sev pre-eclampsia before term. 2018. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK535829\/. Accessed 15 July 2021"},{"issue":"3","key":"1_CR111","doi-asserted-by":"publisher","first-page":"173","DOI":"10.5603\/GP.2019.0030","volume":"90","author":"S Kwiatkowski","year":"2019","unstructured":"Kwiatkowski S, Kwiatkowska E, Torbe A (2019) The role of disordered angiogenesis tissue markers (sflt-1, Plgf) in present day diagnosis of preeclampsia. Ginekol Pol 90(3):173\u2013176","journal-title":"Ginekol Pol"},{"key":"1_CR112","doi-asserted-by":"publisher","first-page":"S954","DOI":"10.1016\/j.ajog.2020.10.024","volume":"226","author":"K Melchiorre","year":"2021","unstructured":"Melchiorre K, Giorgione V, Thilaganathan B (2021) The placenta and preeclampsia: villain or victim? Am J Obstet Gynecol 226:S954\u2013S962","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"1_CR113","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1404595","volume":"372","author":"LA Magee","year":"2015","unstructured":"Magee LA, von Dadelszen P, Rey E et al (2015) Less-tight versus tight control of hypertension in pregnancy. N Engl J Med 372(5):407\u2013417","journal-title":"N Engl J Med"},{"issue":"9694","key":"1_CR114","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0140-6736(09)60736-4","volume":"374","author":"CM Koopmans","year":"2009","unstructured":"Koopmans CM, Bijlenga D, Groen H et al (2009) Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks\u2019 gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 374(9694):979\u2013988","journal-title":"Lancet"},{"issue":"10204","key":"1_CR115","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/S0140-6736(19)31963-4","volume":"394","author":"LC Chappell","year":"2019","unstructured":"Chappell LC, Brocklehurst P, Green ME et al (2019) Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial. Lancet 394(10204):1181\u20131190","journal-title":"Lancet"},{"issue":"5","key":"1_CR116","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jsgi.2005.03.004","volume":"12","author":"VA Rodie","year":"2005","unstructured":"Rodie VA, Young A, Jordan F, Sattar N, Greer IA, Freeman DJ (2005) Human placental peroxisome proliferator-activated receptor \u03b4 and \u03b3 expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction. J Soc Gynecol Investig 12(5):320\u2013329","journal-title":"J Soc Gynecol Investig"},{"issue":"3","key":"1_CR117","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.placenta.2009.12.009","volume":"31","author":"SJ Holdsworth-Carson","year":"2010","unstructured":"Holdsworth-Carson SJ, Lim R, Mitton A et al (2010) Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: gestational diabetes mellitus, intrauterine growth restriction and preeclampsia. Placenta 31(3):222\u2013229","journal-title":"Placenta"},{"issue":"1\u20132","key":"1_CR118","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0378-3782(02)00069-5","volume":"69","author":"J Laasanen","year":"2002","unstructured":"Laasanen J, Heinonen S, Hiltunen M, Mannermaa A, Laakso M (2002) Polymorphism in the peroxisome proliferator-activated receptor-gamma gene in women with preeclampsia. Early Hum Dev 69(1\u20132):77\u201382","journal-title":"Early Hum Dev"},{"issue":"5","key":"1_CR119","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1161\/HYPERTENSIONAHA.111.179440","volume":"58","author":"FP McCarthy","year":"2011","unstructured":"McCarthy FP, Drewlo S, English FA et al (2011) Evidence implicating peroxisome proliferator-activated receptor-? In the pathogenesis of preeclampsia. Hypertension 58(5):882\u2013887","journal-title":"Hypertension"},{"issue":"2","key":"1_CR120","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1161\/HYPERTENSIONAHA.111.172627","volume":"58","author":"FP McCarthy","year":"2011","unstructured":"McCarthy FP, Drewlo S, Kingdom J, Johns EJ, Walsh SK, Kenny LC (2011) Peroxisome proliferator-activated receptor-\u03b3 as a potential therapeutic target in the treatment of preeclampsia. Hypertension 58(2):280\u2013286","journal-title":"Hypertension"},{"issue":"1","key":"1_CR121","doi-asserted-by":"publisher","first-page":"31","DOI":"10.29271\/jcpsp.2018.01.31","volume":"28","author":"HIG Ahham","year":"2018","unstructured":"Ahham HIG, Masri AAA (2018) The potential therapeutic role of peroxisome ProliferatorActivated receptors agonist in Preeclamptic pregnant rats. J Coll Physicians Surg Pak 28(1):31\u201335","journal-title":"J Coll Physicians Surg Pak"},{"issue":"2","key":"1_CR122","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1210\/jc.2004-0849","volume":"90","author":"LL Waite","year":"2005","unstructured":"Waite LL, Louie RE, Taylor RN (2005) Circulating activators of peroxisome proliferator-activated receptors are reduced in preeclamptic pregnancy. J Clin Endocrinol Metab 90(2):620\u2013626","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1_CR123","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.placenta.2010.07.009","volume":"31","author":"T Pl\u00f6sch","year":"2010","unstructured":"Pl\u00f6sch T, Gellhaus A, Van Straten EME et al (2010) The liver X receptor (LXR) and its target gene ABCA1 are regulated upon low oxygen in human trophoblast cells: a reason for alterations in preeclampsia? Placenta 31(10):910\u2013918","journal-title":"Placenta"},{"key":"1_CR124","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.placenta.2010.06.015","volume":"31","author":"MS Weedon-Fekjaer","year":"2010","unstructured":"Weedon-Fekjaer MS, Johnsen GM, Anthonisen EH et al (2010) Expression of liver X receptors in pregnancies complicated by preeclampsia. Placenta 31:818\u2013824","journal-title":"Placenta"},{"issue":"10","key":"1_CR125","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163742","volume":"11","author":"J Wang","year":"2016","unstructured":"Wang J, Dong X, Wu H-Y et al (2016) Relationship of liver X receptors \u03b1 and Endoglin levels in serum and placenta with preeclampsia. PLoS One 11(10):e0163742","journal-title":"PLoS One"},{"key":"1_CR126","unstructured":"Preterm birth. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/preterm-birth. Accessed 5 Aug 2021"},{"key":"1_CR127","unstructured":"Newborns: improving survival and well-being. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/newborns-reducing-mortality. Accessed 5 Aug 2021"},{"issue":"4","key":"1_CR128","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00281-020-00817-w","volume":"42","author":"E Bayar","year":"2020","unstructured":"Bayar E, Bennett PR, Chan D, Sykes L, MacIntyre DA (2020) The pregnancy microbiome and preterm birth. Semin Immunopathol 42(4):487\u2013499","journal-title":"Semin Immunopathol"},{"issue":"7","key":"1_CR129","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1053\/j.semperi.2017.07.011","volume":"41","author":"KM Rood","year":"2017","unstructured":"Rood KM, Buhimschi CS (2017) Genetics, hormonal influences, and preterm birth. Semin Perinatol 41(7):401\u2013408","journal-title":"Semin Perinatol"},{"issue":"7","key":"1_CR130","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1053\/j.semperi.2017.07.013","volume":"41","author":"AN Talati","year":"2017","unstructured":"Talati AN, Hackney DN, Mesiano S (2017) Pathophysiology of preterm labor with intact membranes. Semin Perinatol 41(7):420\u2013426","journal-title":"Semin Perinatol"},{"issue":"10280","key":"1_CR131","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/S0140-6736(21)00217-8","volume":"397","author":"LA Stewart","year":"2021","unstructured":"Stewart LA, Simmonds M, Duley L et al (2021) Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials. Lancet 397(10280):1183\u20131194","journal-title":"Lancet"},{"issue":"3","key":"1_CR132","doi-asserted-by":"publisher","first-page":"223.e1","DOI":"10.1016\/j.ajog.2013.01.020","volume":"208","author":"C Nold","year":"2013","unstructured":"Nold C, Maubert M, Anton L, Yellon S, Elovitz MA (2013) Prevention of preterm birth by progestational agents: what are the molecular mechanisms? Am J Obstet Gynecol 208(3):223.e1","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"1_CR133","doi-asserted-by":"publisher","first-page":"846.e1","DOI":"10.1016\/j.ajog.2015.08.010","volume":"213","author":"A-E Furcron","year":"2015","unstructured":"Furcron A-E, Romero R, Plazyo O et al (2015) Vaginal progesterone, but not 17\u03b1-hydroxyprogesterone caproate, has antiinflammatory effects at the murine maternal-fetal interface. Am J Obstet Gynecol 213(6):846.e1","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"1_CR134","doi-asserted-by":"publisher","first-page":"455.e1","DOI":"10.1016\/j.ajog.2010.03.025","volume":"202","author":"RJ Kuon","year":"2010","unstructured":"Kuon RJ, Shi S-Q, Maul H et al (2010) Pharmacological actions of progestins to inhibit cervical ripening and prevent delivery depend upon their properties, the route of administration and the vehicle. Am J Obstet Gynecol 202(5):455.e1","journal-title":"Am J Obstet Gynecol"}],"container-title":["Advances in Experimental Medicine and Biology","Nuclear Receptors in Human Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-11836-4_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T06:04:48Z","timestamp":1663221888000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-11836-4_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9783031118357","9783031118364"],"references-count":134,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-11836-4_1","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-031-11836-4","asserted-by":"object"}]},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"16 September 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}